Medical dressing with sodium carboxymethylcellulose/polylactic acid sponge protection layer

A technology of sodium carboxymethyl cellulose and polylactic acid, applied in dressings, viscous dressings, medical science and other directions, can solve the problems of poor use compliance, poor fixation performance, strong sense of restraint, etc. Healing, good fixation effect, improved fixation effect

Inactive Publication Date: 2014-12-17
TIANJIN PHARMACN MEDICAL TECH
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in order to ensure that the surface is breathable and movable, the general dressing base layer often adopts materials with high air permeability, low elastic modulus, and high elongation, but this material has poor fixation performance. When it is fixed to a certain extent, it cannot meet the needs, and the medical thermoplastic polyurethane resin (TPU) film has a high elastic modulus, which can fix the wound well, but it is completely airtight, the sense of restraint is too strong, and the use compliance not good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical dressing with sodium carboxymethylcellulose/polylactic acid sponge protection layer
  • Medical dressing with sodium carboxymethylcellulose/polylactic acid sponge protection layer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The preparation method of sodium carboxymethyl cellulose / polylactic acid sponge, adopts the aqueous solution of sodium carboxymethyl cellulose of 5% concentration by weight and the α-pyrrolidone solution of polylactic acid of 2% concentration by weight and then undergoes vacuum freezing It is dry prepared, and the volume ratio of sodium carboxymethyl cellulose solution and α-pyrrolidone solution of polylactic acid is 1:1.

[0009] Such as figure 1 In the dressing shown, the base fabric is rectangular, the base fabric 1 has a viscose layer 2, the middle part of the base fabric 1 is pasted with a protective layer 3 on the viscose layer 2, and the protective layer is sodium carboxymethyl cellulose / polylactic acid sponge with a thickness of 1.5 mm, the protective layer 3 is covered with a release paper 4 , and the outer edge of the release paper 4 is fixed on the corresponding exposed part around the base cloth 1 .

[0010] The outer side of the base cloth 1 adopts the med...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
Login to view more

Abstract

A medical dressing with a sodium carboxymethylcellulose/polylactic acid sponge protection layer is provided with elastic webbing serving as base cloth (1), the base cloth is rectangular or is in a rounded rectangle shape, the inner face of the base cloth is coated with a mucilage glue layer (2), the protection layer (3) is stuck on the mucilage glue layer in the middle of the base cloth and is made of a sodium carboxymethylcellulose/polylactic acid sponge, the thickness of the protection layer is 1-2 mm, the protection layer is covered with separating paper (4), and the outer edge of the separating paper is fixed to the corresponding exposed part of the periphery of the base cloth. The medical dressing with the sodium carboxymethylcellulose/polylactic acid sponge protection layer is characterized in that a medical TPU film fixed on the outer side of the base cloth in a hot pressing mode serves as a reinforcing rib layer (5), the reinforcing rib layer is composed of X-type reinforcing ribs (5.1, 5.2, 5.3 and 5.4) and a boundary reinforcing rib (5.5), the boundary reinforcing rib (5.5) and the two long sides of the base cloth are crossed at the boundary points (5.51 and 5.52), the X-type reinforcing ribs are connected with the boundary points and the four corners of the base cloth to form two X types, the width of the reinforcing ribs is 5-10% of the width of the base cloth, and the thickness of the reinforcing rib layer is 0.1-0.5 mm.

Description

field of invention [0001] The invention relates to a medical dressing. Background technique [0002] Medical dressings generally include an adhesive layer, a base cloth and a protective layer, which are attached to the surface of the wound through the protective layer to prevent further infection of the wound. However, in order to ensure that the surface is breathable and movable, the general dressing base layer often adopts materials with high air permeability, low elastic modulus, and high elongation, but this material has poor fixation performance. When it is fixed to a certain extent, it cannot meet the needs, and the medical thermoplastic polyurethane resin (TPU) film has a high elastic modulus, which can fix the wound well, but it is completely airtight, the sense of restraint is too strong, and the use compliance not good. Invention content: [0003] The invention provides a medical dressing with a protective layer of sodium carboxymethyl cellulose / polylactic acid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61F13/02A61L15/28A61L15/26A61L15/24
CPCA61F13/0236A61F13/0243A61L15/24A61L15/26A61L15/28
Inventor 田东奎何磊
Owner TIANJIN PHARMACN MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products